Ready-To-Use Products Spur the European Tissue Sealants and Topical Hemostats Markets, Says Frost ...( LONDON Jan. 27 /- Cannibalisation hig...),Health

LONDON, Jan. 27 /PRNewswire/ -- Cannibalisation, high market complexity and significant barriers to entry are all influencing the European tissue sealants and topical hemostats markets. However, the increase in complex surgeries and anticipated technology innovations are continuing to drive growth. Ready-to-use products will ensure market expansion.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Tissue Sealants and Topical Hemostats Market, finds that the markets earned revenues of $338.5 million in 2007 and estimates this to reach $645.6 million in 2014.

"The European tissue sealants and topical hemostats markets are driven primarily by the need for quicker and more effective surgeries," notes the Frost & Sullivan analyst. "Additionally, combination products and ready-to-use patches will invigorate market revenues."

The ability to reduce post-operative times will also boost the sale of ready-to-use patches. In addition, fibrin sealants should expand beyond typical wound care applications to be used as drug delivery mechanisms and in adhesion prevention, thus increasing the scope of the market in the future.

However, the dominance of a few large participants will deter the entry of new competitors with innovative products. Furthermore, the lack of proper product positioning will trigger cannibalisation in the market.

"There are high entry barriers in the European tissue sealants and topical hemostats markets," Frost & Sullivan explains. "Apart from domination by a handful of large companies, regulatory issues and the long gestation period also affect the entry of prospective participants. The
'/>"/>